发明名称 |
Anilino liver X-receptor modulators |
摘要 |
The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula I and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically effective dose of a compound of Formula I.
|
申请公布号 |
US2004087632(A1) |
申请公布日期 |
2004.05.06 |
申请号 |
US20030444349 |
申请日期 |
2003.05.23 |
申请人 |
PHARMACIA CORPORATION |
发明人 |
VAN CAMP JENNIFER ANN;MALECHA JAMES W.;MIYASHIRO JULIE M.;DECRESCENZO GARY A.;COLLINS JOE T.;KALMAN MONICA J. |
分类号 |
C07D295/18;A61K31/136;A61K31/165;A61K31/198;A61K31/216;A61K31/222;A61K31/223;A61K31/351;A61K31/40;A61K31/401;A61K31/4406;A61K31/445;A61K31/4468;A61K31/47;A61K31/5375;A61P3/06;A61P3/10;A61P9/10;A61P25/28;C07C215/16;C07C215/68;C07C217/08;C07C219/06;C07C225/06;C07C229/18;C07C229/28;C07C229/36;C07C229/48;C07C237/06;C07C259/06;C07D207/16;C07D211/60;C07D211/62;C07D213/36;C07D213/38;C07D215/06;C07D215/14;C07D295/185;C07D309/14;C07D335/02;(IPC1-7):A61K31/44;A61K31/195 |
主分类号 |
C07D295/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|